Pulmonary severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children is generally described as mild, and SARS-CoV-2 infection in immunocompromised children are observed as generally mild as well. A small proportion of pediatric patients will become critically ill due to (cardio)respiratory failure and require intensive care treatment. We report the case of a teenager with Hodgkin's lymphoma who acquired SARS-CoV-2 (detected by PCR) on the day of her autologous stem cell transplant and developed acute respiratory distress syndrome, successfully treated with a combination of antivirals, immunomodulation with steroids and biologicals, and ECMO.
Keywords: COVID-19; immunodeficient; immunomodulation; pediatric; stem cell transplant.
Copyright © 2022 van der Velden, van Delft, Owens, Llevadias, McKean, Pulford, Taha, Williamson, Campbell-Hewson, Hambleton, Payne, Duncan, Johnston, Spegarova and Emonts.